Axsome Therapeutics (AXSM) PT Raised to $200 at Guggenheim
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $200.00 (from $158.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
